245 related articles for article (PubMed ID: 32920733)
41. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
[TBL] [Abstract][Full Text] [Related]
42. Radiomic analysis on magnetic resonance diffusion weighted image in distinguishing triple-negative breast cancer from other subtypes: a feasibility study.
Wang Q; Mao N; Liu M; Shi Y; Ma H; Dong J; Zhang X; Duan S; Wang B; Xie H
Clin Imaging; 2021 Apr; 72():136-141. PubMed ID: 33242692
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.
Xu HD; Zhang YQ
Neoplasma; 2017; 64(3):430-436. PubMed ID: 28253722
[TBL] [Abstract][Full Text] [Related]
44. Dynamic contrast-enhanced and diffusion-weighted MRI of invasive breast cancer for the prediction of sentinel lymph node status.
Choi EJ; Youk JH; Choi H; Song JS
J Magn Reson Imaging; 2020 Feb; 51(2):615-626. PubMed ID: 31313393
[TBL] [Abstract][Full Text] [Related]
45. Triple-negative breast cancer: Pretreatment magnetic resonance imaging features and clinicopathological factors associated with recurrence.
Lee YJ; Youn IK; Kim SH; Kang BJ; Park WC; Lee A
Magn Reson Imaging; 2020 Feb; 66():36-41. PubMed ID: 31785544
[TBL] [Abstract][Full Text] [Related]
46. The diagnostic performance of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in evaluating the pathological response of breast cancer to neoadjuvant chemotherapy: A meta-analysis.
Li Z; Li J; Lu X; Qu M; Tian J; Lei J
Eur J Radiol; 2021 Oct; 143():109931. PubMed ID: 34492627
[TBL] [Abstract][Full Text] [Related]
47. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
[TBL] [Abstract][Full Text] [Related]
48. Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancer.
Nemeth A; Chaudet P; Leporq B; Heudel PE; Barabas F; Tredan O; Treilleux I; Coulon A; Pilleul F; Beuf O
MAGMA; 2021 Dec; 34(6):833-844. PubMed ID: 34255206
[TBL] [Abstract][Full Text] [Related]
49. Diffusion-weighted MRI for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: evaluation with mono-, bi-, and stretched-exponential models.
Suo S; Yin Y; Geng X; Zhang D; Hua J; Cheng F; Chen J; Zhuang Z; Cao M; Xu J
J Transl Med; 2021 Jun; 19(1):236. PubMed ID: 34078388
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
[TBL] [Abstract][Full Text] [Related]
51. Quantitative multiparametric MRI predicts response to neoadjuvant therapy in the community setting.
Virostko J; Sorace AG; Slavkova KP; Kazerouni AS; Jarrett AM; DiCarlo JC; Woodard S; Avery S; Goodgame B; Patt D; Yankeelov TE
Breast Cancer Res; 2021 Nov; 23(1):110. PubMed ID: 34838096
[TBL] [Abstract][Full Text] [Related]
52. Four-Dimensional Machine Learning Radiomics for the Pretreatment Assessment of Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy in Dynamic Contrast-Enhanced MRI.
Caballo M; Sanderink WBG; Han L; Gao Y; Athanasiou A; Mann RM
J Magn Reson Imaging; 2023 Jan; 57(1):97-110. PubMed ID: 35633290
[TBL] [Abstract][Full Text] [Related]
53. Morphological and Semiquantitative Kinetic Analysis on Dynamic Contrast Enhanced MRI in Triple Negative Breast Cancer Patients.
Gigli S; Amabile MI; David E; De Luca A; Grippo C; Manganaro L; Monti M; Ballesio L
Acad Radiol; 2019 May; 26(5):620-625. PubMed ID: 30145205
[TBL] [Abstract][Full Text] [Related]
54. Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial.
Golshan M; Wong SM; Loibl S; Huober JB; O'Shaughnessy J; Rugo HS; Wolmark N; Ansell P; Maag D; Sullivan DM; Metzger-Filho O; Von Minckwitz G; Geyer CE; Sikov WM; Untch M
Eur J Surg Oncol; 2020 Feb; 46(2):223-228. PubMed ID: 31606288
[TBL] [Abstract][Full Text] [Related]
55. Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.
Bufi E; Belli P; Costantini M; Cipriani A; Di Matteo M; Bonatesta A; Franceschini G; Terribile D; Mulé A; Nardone L; Bonomo L
Clin Breast Cancer; 2015 Oct; 15(5):370-80. PubMed ID: 25891905
[TBL] [Abstract][Full Text] [Related]
56. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
[TBL] [Abstract][Full Text] [Related]
57. Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer.
Minarikova L; Bogner W; Pinker K; Valkovič L; Zaric O; Bago-Horvath Z; Bartsch R; Helbich TH; Trattnig S; Gruber S
Eur Radiol; 2017 May; 27(5):1901-1911. PubMed ID: 27651141
[TBL] [Abstract][Full Text] [Related]
58. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
[TBL] [Abstract][Full Text] [Related]
59. Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.
Aribal E; Asadov R; Ramazan A; Ugurlu MÜ; Kaya H
Eur J Radiol; 2016 May; 85(5):979-86. PubMed ID: 27130059
[TBL] [Abstract][Full Text] [Related]
60. Development and validation of peritumoral vascular and intratumoral radiomics to predict pathologic complete responses to neoadjuvant chemotherapy in patients with triple-negative breast cancer.
Xie T; Gong J; Zhao Q; Wu C; Wu S; Peng W; Gu Y
BMC Med Imaging; 2024 Jun; 24(1):136. PubMed ID: 38844842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
